中文名称 | 英文名称 | CAS号 | 化学式 | 分子量 |
---|---|---|---|---|
4-溴-2.6-二甲酸甲酯吡啶 | dimethyl 4-bromo-2,6-pyridinedicarboxylate | 162102-79-6 | C9H8BrNO4 | 274.071 |
4-溴吡啶-2,6-二羧酸二乙酯 | diethyl 4-bromo-2,6-pyridinedicarboxylate | 112776-83-7 | C11H12BrNO4 | 302.125 |
4-氧代-1,4-二氢-2,6-吡啶二甲酸 | Chelidamic acid | 138-60-3 | C7H5NO5 | 183.12 |
—— | 4-bromopyridine-2,6-dicarbonyl dibromide | 120491-93-2 | C7H2Br3NO2 | 371.81 |
中文名称 | 英文名称 | CAS号 | 化学式 | 分子量 |
---|---|---|---|---|
4-溴-2.6-二甲酸甲酯吡啶 | dimethyl 4-bromo-2,6-pyridinedicarboxylate | 162102-79-6 | C9H8BrNO4 | 274.071 |
4-溴-6-(甲氧基羰基)甲酸吡啶 | 4-bromo-6-(methoxycarbonyl)pyridine-2-carboxylic acid | 293294-72-1 | C8H6BrNO4 | 260.044 |
4-溴吡啶-2,6-二羧酸二乙酯 | diethyl 4-bromo-2,6-pyridinedicarboxylate | 112776-83-7 | C11H12BrNO4 | 302.125 |
4-溴-6-(羟甲基)吡啶甲酸乙酯 | ethyl 4-bromo-6-(hydroxymethyl)picolinate | 1001415-17-3 | C9H10BrNO3 | 260.087 |
4-溴吡啶-2,6-二甲醇 | 4-bromo-2,6-pyridinedimethanol | 120491-88-5 | C7H8BrNO2 | 218.05 |
4-溴-2,6-二甲酰基吡啶 | 4-bromopyridine-2,6-dicarbaldehyde | 128184-01-0 | C7H4BrNO2 | 214.018 |
—— | methyl 4-bromo-6-(N,N-diethylcarbamoyl)pyridine-2-carboxylate | 350048-11-2 | C12H15BrN2O3 | 315.167 |
—— | 4-Bromopyridine-2,6-dicarbonyl dichloride | 206647-42-9 | C7H2BrCl2NO2 | 282.908 |
—— | 4-bromo-2,6-diacetylpyridine | 1393570-07-4 | C9H8BrNO2 | 242.072 |
Lead generation and the associated hit-to-lead process are key strategic elements in modern pharmaceutical research, and most companies have implemented this concept. Efficient lead generation is one of the main attempts to reduce the high attrition rates observed along the drug discovery process by focussing on the early developmental phases. The level of integration of the lead generation activities within the discovery organization, the flexibility in assessing and implementing new chemistries and new technologies, the high-quality standards set for the identification of the best possible chemical lead series will ultimately determine the future success in discovering new medicines.